BSX Loss Alert: Boston Scientific class action lawsuit offers investors a path to recovery.

NEW YORK, March 24, 2026 – The Gross Law Firm has issued a notification to investors holding shares of Boston Scientific Corporation (NYSE: BSX). The firm encourages shareholders who purchased BSX stock during the specified class period to contact them regarding potential appointment as a lead plaintiff.

According to Ranked Stocks' quantitative analysis, Boston Scientific (BSX) currently holds an RS Score of 51.96. This places the company in the 10.20th percentile within its country and the 7.14th percentile within its sector. The stock demonstrates strength in Profitability, scoring 80.40. However, it shows weaker performance in other key areas, with scores of 46.92 for Valuation, 14.10 for Growth, 8.38 for Momentum, and 70.00 for EPS Revisions. Want to discover which stocks rank the highest? Start your free 7-day trial at rankedstocks.com.